Photo

613-801-0450

...

Ottawa

English

Claire Palmer, Ph.D.

Senior Patent Agent

Claire drafts and prosecutes patents in a broad range of technologies, including biotechnology, biochemistry, pharmaceuticals, microbiology, biology, molecular biology, bioremediation, bioinformatics, biological wastewater treatment and other "green" technologies. Claire also has expertise in the Patented Medicines (Notice of Compliance) Regulations, particularly on issues relating to patent claim eligibility for listing patents and issues relating to the Patented Medicines Price Review Board.

Claire’s experience in the fields of scientific research revolves around projects relating to bacterial DNA repair, chromatin remodelling, transcriptional regulation and myogenesis. The latter project specifically included analyzing the changes to histone modifications that occur during muscle differentiation and the role of ATP-dependent chromatin remodelling motors in myogenesis.

Her expertise extends to a variety of scientific techniques, including a wide range of molecular biology, gene arrays, transcriptional assays and cell culture techniques.

Claire is a registered patent agent in Canada and has limited recognition to represent Canadians in patent matters before the USPTO. Her practice also extends to assisting in patent litigation matters.

In her spare time, Claire is an avid year-round cyclist who enjoys exploring the world on her bike.

Education

  • Hon. B.Sc., Biology, McMaster University

  • M.Sc., Microbiology, McMaster University

  • Ph.D., Molecular Biology, McMaster University

PRACTICE AREA

  • Patent strategy, drafting and prosecution

Technology AREA

  • Biotech
  • Chemical
  • Pharma
  • Bioremediation

Professional Involvement

  • Intellectual Property Institute of Canada (IPIC)

cb photo 106 56b90c1f32572

DR. Michael Maskery

Patent Agent


Michael's practice focuses on the patent drafting, prosecution and strategy in a variety of technology fields.MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More